Dexamethasone Delivery Enhances Bone Regeneration in 3D Scaffolds

Introduction to Bone Regeneration and Tissue Engineering

Bone regeneration is a critical area of research in tissue engineering, particularly for patients suffering from conditions that result in bone loss or defects, such as traumatic injuries, tumors, or metabolic diseases. Traditional methods of bone repair often involve the use of autografts or allografts, which come with significant limitations including donor site morbidity, limited availability, and the risk of disease transmission. As a result, there has been a growing interest in developing advanced biomaterials that can enhance the natural healing processes of bone. Tissue engineering combines the principles of biology, materials science, and engineering to create scaffolds that support the growth of new bone tissue.

One of the most promising strategies in tissue engineering is the use of three-dimensional (3D) printed scaffolds that can mimic the architecture and mechanical properties of natural bone. These scaffolds can be designed to provide structural support while also delivering bioactive compounds that promote cell proliferation and differentiation, thereby facilitating bone regeneration. Recent advancements in 3d printing technology allow for the precise control of scaffold design, including porosity, surface topography, and mechanical properties, which are crucial for successful bone tissue engineering (Noory et al., 2025).

Overview of Dexamethasone’s Role in Osteogenic Differentiation

Dexamethasone (DEX), a synthetic glucocorticoid, has been extensively studied for its effects on bone metabolism. It is known to influence the differentiation of mesenchymal stem cells (MSCs) into osteoblasts, the cells responsible for bone formation. DEX enhances the expression of bone-specific genes such as collagen I, osteonectin, and RUNX2, which are crucial for osteogenic differentiation. Additionally, DEX promotes mineralization, a key step in the formation of mature bone tissue.

However, the use of DEX in clinical settings has been limited due to its potential side effects, including osteoporosis and impaired wound healing. To maximize the benefits of DEX while minimizing adverse effects, controlled delivery systems have been developed. These systems can provide sustained release of DEX over time, allowing for more effective treatment outcomes in bone regeneration (Noory et al., 2025).

Importance of 3D Printing in Scaffold Fabrication for Bone Repair

The advent of 3D printing technology has revolutionized the field of tissue engineering, particularly in the fabrication of scaffolds for bone repair. 3D printing enables the creation of complex geometries that can closely mimic the architecture of natural bone, including features such as porosity and interconnectivity. This is essential for facilitating cellular ingrowth, nutrient diffusion, and vascularization within the scaffold.

One of the key advantages of 3D-printed scaffolds is the ability to tailor their mechanical properties to match those of the bone they aim to replace. For instance, scaffolds made from polycaprolactone (PCL) combined with hydroxyapatite (HA) have shown promising results in terms of mechanical strength and biocompatibility. Moreover, the incorporation of bioactive compounds, such as DEX, into these scaffolds can further enhance their osteogenic potential, promoting effective bone healing and regeneration (Noory et al., 2025).

Hybrid Scaffolds: Combining Polycaprolactone and Hydrogel for Enhanced Performance

Hybrid scaffolds that combine synthetic polymers like PCL with natural hydrogels such as alginate and gelatin represent a novel approach in bone tissue engineering. These hybrid systems leverage the mechanical strength of PCL while utilizing the biocompatibility and bioactivity of hydrogels. The combination allows for the sustained release of bioactive compounds, which is critical for enhancing osteogenic differentiation.

In a recent study, scaffolds were fabricated using a layer-by-layer 3D printing technique, incorporating DEX-loaded PCL microparticles within an alginate-gelatin hydrogel. This design not only supports the mechanical integrity of the scaffold but also facilitates the controlled release of DEX, promoting the osteogenic differentiation of human endometrial mesenchymal stem cells (hEnMSCs). The results indicated significant increases in the expression of osteogenic markers and enhanced mineralization compared to scaffolds without DEX (Noory et al., 2025).

Table 1: Summary of Scaffold Composition and Properties

Scaffold Type	Composition	Mechanical Properties	Drug Release Profile
PCL-nHA	PCL and nHA	High compressive strength	Moderate initial burst
Alg-Gel	Alginate and Gelatin	Low compressive strength	Rapid degradation
Hyb-1	PCL-nHA + Alg-Gel (layered)	Moderate compressive strength	Sustained release of DEX
Hyb-2	PCL-nHA + Alg-Gel (interspersed)	Moderate compressive strength	Controlled release

Results and Discussion: Evaluating the Efficacy of Drug-Loaded Scaffolds

The efficacy of DEX-loaded hybrid scaffolds was evaluated through in vitro studies assessing their effects on hEnMSCs. The results demonstrated that scaffolds with controlled DEX release significantly enhanced osteogenic differentiation compared to those without DEX. Key indicators of osteogenic differentiation, including collagen I, osteonectin, and RUNX2, were upregulated in the presence of DEX-loaded scaffolds.

Moreover, alkaline phosphatase (ALP) activity, a marker of early osteoblast differentiation, was significantly higher in the DEX-loaded groups. This suggests that the sustained release of DEX from the hybrid scaffolds not only supports cell proliferation but also stimulates the differentiation process critical for effective bone regeneration.

Table 2: Gene Expression Analysis of Osteogenic Markers

Scaffold Type	Gene Expression (COL1A1)	Gene Expression (OST)	Gene Expression (RUNX2)
PCL-nHA	Low	Low	Low
Alg-Gel	Moderate	Moderate	Moderate
Hyb-1	High	High	High
Hyb-1-DEX	Very High	Very High	High

The histological analysis of mineralization using Alizarin Red staining revealed that DEX-loaded scaffolds facilitated increased calcium deposition compared to control scaffolds. This is a promising indication of the scaffolds’ potential for use in clinical applications for bone repair.

FAQ

What is dexamethasone and how does it help in bone regeneration?

Dexamethasone is a synthetic glucocorticoid that promotes osteogenic differentiation in mesenchymal stem cells, enhancing the expression of bone-specific genes and facilitating mineralization.

Why are hybrid scaffolds advantageous for bone tissue engineering?

Hybrid scaffolds combine the mechanical properties of synthetic polymers with the biocompatibility of natural hydrogels, allowing for controlled release of bioactive compounds and mimicking the extracellular matrix of bone.

How does 3D printing contribute to scaffold development?

3D printing allows for precise control over scaffold design, including porosity and structural integrity, which are essential for effective bone regeneration.

What are the implications of this research for clinical applications?

The development of DEX-loaded 3D-printed hybrid scaffolds offers a promising approach for enhancing bone regeneration in patients with large bone defects, potentially improving clinical outcomes.

What future research directions are suggested?

Further studies are needed to explore the in vivo efficacy of these hybrid scaffolds and optimize their design for improved drug delivery and mechanical performance.

References

Noory, P., Farmani, A. R., Ai, J., Bahrami, N., Ebrahimi-Barough, S., Farzin, A., Shojaie, S., Hajmoradi, H., Mohamadnia, A., & Goodarzi, A. (2025). Enhancing in vitro osteogenic differentiation of mesenchymal stem cells via sustained dexamethasone delivery in 3D-Printed hybrid scaffolds based on polycaprolactone-nanohydroxyapatite/alginate-gelatin for bone regeneration. Journal of Biological Engineering, 16, 1-14. https://doi.org/10.1186/s13036-025-00514-y
Zhang, Y., Luo, P., Tang, Y., Wang, J., Gao, S., Fan, Y. C., & Wang, K. (2025). Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): data from the NHANES III (1988–1994). Nutrition & Metabolism, 272. https://doi.org/10.1186/s12986-025-00942-z
Zhao, J., Li, N., Li, S., Dou, J. (2025). The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study. Cardiovascular Diabetology, 16, 1-10. https://doi.org/10.1186/s12933-025-02783-9
Kuang, Z., Li, R., Lu, S., Wang, Y., Luo, Y., Shen, Y., Yuan, L., Yang, Y., Song, Z., Jiang, N., & Tong, C. (2025). Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study. World Journal of Emergency Medicine, 16(3), 1-9
Dingping, J., Chen, L., Wu, S., Ren, J., Zhang, H., Wu, X., Lu, L., Ma, H., & Feng, X. (2025). Association between serum creatinine levels at emergency admission and outcomes in patients with exertional heat stroke: a multicenter cohort study. World Journal of Emergency Medicine, 16(3), 1-8